VivoSeq
Other

Endoscopy

0

Pipeline Programs

0

Active Trials

4

Companies Involved

Endoscopy is an early-stage landscape with 0 programs across 4 companies. The most active players are Nihon Pharmaceutical Co., Ltd, Merck & Co., Novartis.

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

11/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

35

clinical trials

Completed20 · 57%
Unknown status11 · 31%
Terminated3 · 9%
Withdrawn1 · 3%

Trial Activity

35 trials

Nasal Prep for Nasendoscopy in Children
Completed··Phase 4·NCT01351298·69 enrolled
Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy
Completed··N/A·NCT03662113·200 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)